2026 AGENDA

Registration

Pacifica Ballroom

Breakfast Symposium: Evidence-Based Treatment of Recurrent Pericarditis

Mariko Harper, MD (Hypertrophic Cardiomyopathy Center of Excellence, Seattle)

Non-CME

Welcome, Introduction & Program Overview

Lori Daniels, MD, MAS, FACC, FAHA, FESC (UC San Diego)

hsTroponin in the Emergency Department

Martin Than, MD (Christchurch Hospital, New Zealand)

Point of Care hsTroponin: Whole-Blood Testing Comes of Age

Paul Collinson, MA, MB, BChir, FRCPath, MD, FRCP(Edin), FAACC, FESC (City St. George’s University of London)

Troponin I or T? Using Both to Sort Type 1 from Type 2—and Acute from Chronic

Fred Apple, PhD, DABCC (University of Minnesota, Minneapolis, MN)

Type 4 MI - Biomarkers, Diagnosis & Controversies

Yader Sandoval, MD, FACC, FSCA (Minneapolis Heart Institute, Minneapolis, MN)

Reflections on the Universal Definition of MI

Nicholas Mills, MD, PhD (University of Edinburgh, UK)

Acute Coronary Syndrome Panel Q&A/Discussion

BREAK / VISIT EXHIBITS 

Everything You Need to Know About Macro Troponins & Troponin Autoantibodies – An Update

Saara Wittfooth, PhD (University of Turku: Turku, Finland)

Do You Need Necrosis? Rethinking Mechanisms of Troponin Release

Ola Hammarsten, MD, PhD (University of Gothenburg, Sweden)

High-Sensitivity Cardiac Troponin: Analytical Pitfalls & Practical Fixes

Robert Fitzgerald, PhD (UC San Diego)

Biomarker-Guided Prevention Interventions in the Emergency Department

Simon Mahler, MD (Wake Forest University, Winston-Salem, NC) 

Using Biomarkers to Advance GDMT ADHEREance

Gregg Fonarow, MD (UC Los Angeles)

Biomarkers for Risk Stratification in Diabetes - A Patient-Based Perspective (Steven Edelman, MD)

Lori Daniels, MD, MAS, FACC, FAHA, FESC (UC San Diego)

Q&A Panel Discussion

Lunch Symposium - Biomarker-Guided Approach for Heart Failure Prevention in Patients with Diabetes

Ambarish Pandey, MD, MSCS, FAHA (UT-Southwestern)

Non-CME

The Clinical Emergence of Lipoprotein (a)

Pam Taub, MD (UC San Diego)

Biomarkers for "Precision-Like" Prevention & Population Health

James De Lemos, MD (University of Texas Southwestern)

GDF-15 as a Therapeutic Target

Kristin Aakre, MD, PhD (University of Bergen, Norway)

Markers of Inflammation & Cardiovascular Disease in Chronic Kidney Disease

Alexander Bullen, MD (UC San Diego)

Age Matters: Principles for Interpreting Biomarkers in Late Life

Christopher deFilippi, MD, MS, FACC (University. of Maryland, Baltimore, MD)

Cardiac Biomarkers & Risk for Dementia

Christie Ballantyne, MD, FACP, FACC (Baylor College of Medicine)

Q&A Panel Discussion

BREAK / VISIT EXHIBITS

A Digital Biomarker for Peripheral Arterial Disease

Mattheus Ramsis, MD (UC San Diego)

Q&A Discussion

The Bed of the Future

Kevin King, MD, PhD (UC San Diego)

Q&A  

A Better Critical Care Biomarker 

Adrian Picod, MD, PhD (Avicenne Hospital Paris, France)

Q&A

Will Secretoneurin Be the Next Big Thing?

Torbjørn Omland, MD, PhD (University of Oslo, Norway)

Q&A

Shark Tank Reveal

Lori Daniels, MD, MAS, FACC, FAHA, FESC (UC San Diego), Christopher deFilippi, MD, MS, FACC (University of Maryland, Baltimore, MD)

Concluding Remarks

Lori Daniels, MD, MAS (UC San Diego)